Novogen Limited (NVGN)
-NasdaqCM 4.10 
0.10(2.38%) 3:59PM EDT
| Prev Close: | 4.20 |
|---|
| Open: | 4.14 |
|---|
| Bid: | 4.10 x 100 |
|---|
| Ask: | 4.17 x 100 |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | 1.21 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 4.10 - 4.22 |
|---|
| 52wk Range: | 0.48 - 10.49 |
|---|
| Volume: | 16,680 |
|---|
| Avg Vol (3m): | 75,117 |
|---|
| Market Cap: | 17.35M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.70 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 12.71 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(0-00-31)
: | N/A |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Novogen Limited, a biotechnology company, engages in the research and development of pharmaceutical products. It focuses on the development of a family of anti-cancer drugs based on comprehensive anti-cancer activity against cancer cells and cance...
View More